PTEN loss in fetal liver hematopoietic stem cells (HSCs) leads to alterations in myeloid, T-, and B-lineage potentials and T-lineage acute lymphoblastic leukemia (T-ALL) development. To explore the mechanism underlying PTEN-regulated hematopoietic lineage choices, we carry out integrated assay for transposase-accessible chromatin using sequencing (ATAC-seq), single-cell RNA-seq, and in vitro culture analyses using in vivo-isolated mouse pre-leukemic HSCs and progenitors. We find that PTEN loss alters chromatin accessibility of key lineage transcription factor (TF) binding sites at the prepro-B stage, corresponding to increased myeloid and T-lineage potentials and reduced B-lineage potential. Importantly, we find that PU.1 is an essential TF downstream of PTEN and that altering PU.1 levels can reprogram the chromatin accessibility landscape and myeloid, T-, and B-lineage potentials in Ptennull prepro-B cells. Our study discovers prepro-B as the key developmental stage underlying PTEN-regulated hematopoietic lineage choices and suggests a critical role of PU.1 in modulating the epigenetic state and lineage plasticity of prepro-B progenitors.
Pubmed ID: 37561626 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets TER-119
View all literature mentionsThis monoclonal targets Siglec H
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets Ly-6A/E
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD48
View all literature mentionsThis monoclonal targets CD43
View all literature mentionsThis monoclonal targets CD43
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets Mouse CD34
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD45R / B220
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis unknown targets CD16/CD32
View all literature mentionsThis monoclonal targets CD150
View all literature mentionsThis monoclonal targets CD135 (FLT3)
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets Itgam
View all literature mentionsThis monoclonal targets Sfpi1
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD117
View all literature mentionsCell line OP9/G-DLL1 is a Stromal cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line OP9 is a Stromal cell line with a species of origin Mus musculus
View all literature mentionsCell line OP9/G-DLL1 is a Stromal cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line OP9 is a Stromal cell line with a species of origin Mus musculus
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis monoclonal targets Sfpi1
View all literature mentionsThis monoclonal targets TER-119
View all literature mentionsThis monoclonal targets Siglec H
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets Ly-6A/E
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD48
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD45R / B220
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD43
View all literature mentionsThis monoclonal targets CD43
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets Mouse CD34
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis unknown targets CD16/CD32
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD150
View all literature mentionsThis monoclonal targets CD135 (FLT3)
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD117
View all literature mentionsThis monoclonal targets Itgam
View all literature mentions